ROSGQ (Rosetta Genomics) Float Percentage Of Total Shares Outstanding: 99.98% (As of Jun. 30, 2026)


What is Rosetta Genomics Float Percentage Of Total Shares Outstanding?

Rosetta Genomics ROSGQ -99.00% Float Percentage Of Total Shares Outstanding is 99.98% as of Jun. 30, 2026.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Rosetta Genomics's float shares is 5.93 Mil. Rosetta Genomics's total shares outstanding is 5.93 Mil. Rosetta Genomics's float percentage of total shares outstanding is 99.98%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Rosetta Genomics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Rosetta Genomics's Institutional Ownership is 3.45%.

Rosetta Genomics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Rosetta Genomics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=5.93/5.93
=99.98%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.98% mean?
Rosetta Genomics (ROSGQ) has a Float Percentage Of Total Shares Outstanding of 99.98% as of Jun. 30, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Rosetta Genomics and its competitors.
Is Rosetta Genomics' Float Percentage Of Total Shares Outstanding too high?
Rosetta Genomics' current Float Percentage Of Total Shares Outstanding is 99.98%.
How does Rosetta Genomics' Float Percentage Of Total Shares Outstanding compare to TEAR and IDTA?
Rosetta Genomics' Float Percentage Of Total Shares Outstanding of 99.98% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Diagnostics & Research company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Diagnostics & Research industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Rosetta Genomics and its competitors. Rosetta Genomics's current Float Percentage Of Total Shares Outstanding is 99.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rosetta Genomics stock overvalued right now?
Rosetta Genomics (ROSGQ) has a current Float Percentage Of Total Shares Outstanding of 99.98%. The current Float Percentage Of Total Shares Outstanding is 99.98%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Rosetta Genomics (ROSGQ), the current Float Percentage Of Total Shares Outstanding is 99.98% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rosetta Genomics Business Description

Address 10 Plaut Street, Science Park, Rehovot, ISR, 76706
Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.